No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy
Panagiotis Baliakas
(1, 2)
,
Mattias Mattsson
(3, 4)
,
Anastasia C Hadzidimitriou
(5)
,
Eva Minga
(5)
,
Andreas C Agathangelidis
(5, 6, 7)
,
Lesley-Ann Sutton
(1, 8)
,
Lydia C Scarfò
(9, 10)
,
Zadie Davi
(11)
,
Xiao-Jie Yan
(12)
,
Karla C Plevova
(13, 14)
,
Yorick Sandberg
(15)
,
Fie Vojdeman
(16)
,
Tatiana Tzenou
(17)
,
Charles Chu
(18)
,
Silvio Veronese
(19)
,
Larry Mansouri
(1, 20)
,
Karin Smedby
(21)
,
Véronique Giudicelli
(22)
,
Florence C Nguyen-Khac
(23)
,
Panagiotis F Panagiotidis
(17)
,
Gunnar Juliusson
(24, 25)
,
Achilles Anagnostopoulos
(26)
,
Marie-Paule Lefranc
(22)
,
Livio Trentin
(27, 28)
,
Mark Catherwood
(29)
,
Marco Montillo
(19)
,
Carsten Niemann
(16)
,
Anton Langerak
(15)
,
Sarka C Pospisilova
(13, 30)
,
Niki Stavroyianni
(26)
,
Nicholas C Chiorazzi
(12)
,
David Davi
(23)
,
Diane Jelinek
(31)
,
Tait Shanafelt
(32)
,
Nikos Darzentas
(14)
,
Chrysoula C Belessi
(33)
,
Frédéric Davi
(23, 23)
,
Paolo C Ghia
(9, 10)
,
Richard Rosenquist
(1, 34, 35)
,
Kostas C Stamatopoulos
(20, 36, 37)
1
Uppsala Universitet [Uppsala]
2 Uppsala University
3 IGP - Department of Immunology, Genetics and Pathology [Uppsala, Sueden]
4 Department of Hematology [Uppsala]
5 Institute of Applied Biosciences, Centre for Research and Technology-Hellas, Thessaloniki, Greece;
6 Università Vita-Salute San Raffaele, Milan, Italy.
7 Strategic Research Program in CLL, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy
8 Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
9 Università Vita e Salute
10 Strategic Research Program in CLL, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
11 Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
12 The Feinstein Institute for Medical Research
13 CEITEC-Central European Institute of Technology, MasarykBrno, Czech Republic.
14 CEITEC MU - Central European Institute of Technology [Brno]
15 Erasmus MC - Erasmus University Medical Center [Rotterdam]
16 Department of Hematology, Rigshospitalet, Copenhagen, Denmark
17 First Department of Propaedeutic Medicine, University of Athens, Athens, Greece
18 The Feinstein Institute for Medical Research
19 Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
20 Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
21 Karolinska University Hospital [Stockholm]
22 IGH - Institut de génétique humaine
23 CHU Pitié-Salpêtrière [AP-HP]
24 Hematology and Transplantation
25 Skane University Hospital [Lund]
26 Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
27 Unipd - Università degli Studi di Padova = University of Padua
28 VIMM - Venetian Institute Molecular Medicine
29 Department of Hemato-Oncology, Belfast City Hospital, Belfast, UK
30 University Hospital Brno
31 Department of Immunology, Mayo Clinic, Rochester, MV, USA
32 Mayo Clinic [Rochester]
33 Hematology Department, Nikea General Hospital, Piraeus, Greece
34 Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
35 Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
36 Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
37 Institute of Applied Biosciences, Thessaloniki, Greece.
2 Uppsala University
3 IGP - Department of Immunology, Genetics and Pathology [Uppsala, Sueden]
4 Department of Hematology [Uppsala]
5 Institute of Applied Biosciences, Centre for Research and Technology-Hellas, Thessaloniki, Greece;
6 Università Vita-Salute San Raffaele, Milan, Italy.
7 Strategic Research Program in CLL, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy
8 Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
9 Università Vita e Salute
10 Strategic Research Program in CLL, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
11 Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
12 The Feinstein Institute for Medical Research
13 CEITEC-Central European Institute of Technology, MasarykBrno, Czech Republic.
14 CEITEC MU - Central European Institute of Technology [Brno]
15 Erasmus MC - Erasmus University Medical Center [Rotterdam]
16 Department of Hematology, Rigshospitalet, Copenhagen, Denmark
17 First Department of Propaedeutic Medicine, University of Athens, Athens, Greece
18 The Feinstein Institute for Medical Research
19 Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
20 Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
21 Karolinska University Hospital [Stockholm]
22 IGH - Institut de génétique humaine
23 CHU Pitié-Salpêtrière [AP-HP]
24 Hematology and Transplantation
25 Skane University Hospital [Lund]
26 Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
27 Unipd - Università degli Studi di Padova = University of Padua
28 VIMM - Venetian Institute Molecular Medicine
29 Department of Hemato-Oncology, Belfast City Hospital, Belfast, UK
30 University Hospital Brno
31 Department of Immunology, Mayo Clinic, Rochester, MV, USA
32 Mayo Clinic [Rochester]
33 Hematology Department, Nikea General Hospital, Piraeus, Greece
34 Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.
35 Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
36 Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
37 Institute of Applied Biosciences, Thessaloniki, Greece.
Andreas C Agathangelidis
- Fonction : Auteur
Véronique Giudicelli
- Fonction : Auteur
- PersonId : 1197166
- IdHAL : veronique-giudicelli
- ORCID : 0000-0002-2258-468X
- IdRef : 224422596
Gunnar Juliusson
- Fonction : Auteur
- PersonId : 887300
Marie-Paule Lefranc
- Fonction : Auteur
- PersonId : 1253455
- ORCID : 0000-0003-0116-9353
- IdRef : 096991046
Anton Langerak
- Fonction : Auteur
- PersonId : 784443
- ORCID : 0000-0002-2078-3220